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Introduction
The post-genomic challenge is coming to consulting
rooms and clinics throughout the United Kingdom
(UK).1 We believe that the project offers four potentially
vital prizes:
 insights into disease mechanisms in the families and
individuals we look after
 a basic resource for science-based therapeutic inno-
vation
 better targeting of preventive and therapeutic inter-
ventions to those most likely to benefit
 building up research capacity in primary care.2–4
Whether primary care engages with the process or not,
the post-genomic revolution will roll on. Clinicians will
be faced with patients who have, or perceive themselves
to have, a health problem related to the new knowledge
being generated by this revolution.
UK Biobank is a prospective cohort study recruit-
ing around 500 000 volunteers aged 45–69 years.5
Patients may be identified from general practitioner
(GP) records or health board lists and invited to
attend for baseline interview and examination. The
project will be overseen by a co-ordinating centre in
Manchester. This will be established as a charitable
company limited by guarantee, to be owned jointly by
the Wellcome Trust and the Medical Research Council
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ABSTRACT
UK Biobank is an ambitious post-genomic project
involving the recruitment and follow-up of 500 000
volunteers aged 45 to 69 years. Many primary care
teams will be involved in the study directly or
indirectly. The programme of research will use at
least five data sources: paper-based questionnaires,
blood samples, genotype information derived from
the bloods, clinical/prescribing data from the medical
records, and data on deaths. We describe three of the
key challenges to primary care informatics posed by
this project: patient recruitment, confidentiality, and
data management. We then describe solutions pro-
posed in Scotland, based on existing technologies.
Some of these may be applicable elsewhere in the
other Regional Collaborating Centres and other large-
scale collaborative projects which rely on primary
care informatics.
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(MRC). There will be six regional collaborating
centres (RCCs), which are responsible for recruitment
around the UK:
 Scottish Consortium
 All Wales Consortium
 Central England Consortium
 Fosse Way Consortium
 London Biobank Consortium
 North West–Wessex Consortium.
The first visit will involve collection of questionnaire
data on health and lifestyle, clinical examination, blood
sampling for genetic and biochemical analyses and
follow-up. Subsequent health outcomes will be ascer-
tained via postal questionnaires and National Health
Service (NHS) medical records, in particular those held
at the general practice level. Therefore, close liaison
with participating general practices will be essential,
not only at the outset but throughout the follow-up
phase. This paper describes three of the principal
challenges to primary care informatics posed by UK
Biobank: patient recruitment, confidentiality and data
management. We then describe solutions proposed in
Scotland, many of which might be applicable elsewhere
in the other RCCs.
Patient recruitment and
retention challenges
No decision has yet been taken about whether study
subjects will be recruited by direct communication 
or through their GPs. If recruitment is via a network
of GPs, then data will need to be acquired about 
the patients from records held on practice computer
systems. If so, some consideration should be given as
to which practices are recruited.6 This might include
eligibility criteria such as:
 a commitment to quality data recording and audit
thereof
 an initial data quality audit 
 a commitment to ensure that the electronic records
for patients recruited are brought fully up to date
 the type of GP systems used must be able to provide
the necessary data.
One of the critical success factors of the Biobank project
will be the completeness and accuracy of the patient
data collected.7 Good primary care information tech-
nology (IT) solutions will be needed throughout the
UK as patients move from place to place, no matter
how initial recruitment occurs.
Confidentiality challenges
The UK Data Protection Act of 1998 has led to major
difficulties for everyone engaged in post-genomic and
epidemiological research using patient data.8,9 Many
believe that methods of working within the legislation
can only be definitively clarified by the courts; however,
few investigators will choose that route.10,11 Debate as
to what research activities may be legally undertaken
has occurred in research ethics committees, scientific
grant awarding bodies, the General Medical Council,
the British Medical Association and the Royal Colleges,
but a unified opinion has not emerged.12,13 Unsurpris-
ingly, Caldicott Guardians and other controllers of
subject-identifiable patient data have been reluctant
to release permission for access to data for fear of
acting unlawfully.14 Failure to achieve a satisfactory
resolution would deprive researchers of access to the
strongest and least biased methodologies, and patients
of the benefits to patient care from projects like UK
Biobank.15 However, because Biobank participants 
are volunteers, many of the barriers can be overcome
provided the consent process includes access to the
appropriate data.
Data management challenges
Biobank will use at least four data sources in the study:
 paper-based questionnaires
 blood samples
genotype information derived from the bloods
 clinical/prescribing data from the medical records
of the cohort
 death data.
The validity, completeness, metadata, structure,
format and accessibility of data in primary care varies
depending on source.16 Not all historical data may be
entered, especially as the cohort will be recruited from
an older population (45–69). There are also problems
arising from the need to follow up patients in the
longer term.
Proposed patient recruitment
and retention solutions
At each participating practice, the master list of patients
may be interrogated to produce a list of eligible sub-
jects aged between 45 and 69 years. In Scotland,
all general practices use the Community Health
Number (CHNo) to maintain practice lists. Indi-
vidual GPs would then be asked to inspect the list of
patients generated for their own practice. They would
remove from this list the name of any individual they
feel it would be inappropriate to contact on behalf of
the UK Biobank project. Reasons for removal could
include inability to provide informed consent and ter-
minal illness. Exclusion may introduce socio-
economic bias and result in the study population
being unrepresentative, therefore strict criteria will be
used to minimise bias. Project staff would only get
patient details once an affirmative response is received
to the GP letter.
Invitations to participate
Letters could be prepared on the headed notepaper of
individual practices. The letter of invitation to partici-
pate in UK Biobank would be signed by the GP to
facilitate recruitment. We know from qualitative pilot
work with patients in the target group that almost all
patients approached are likely to agree to participate.17
Monthly and quarterly review of recruitment rates
would be conducted to identify and address problem
areas.
Confidentiality solutions
Consent 
At the screening visit each individual would be invited
to consent specifically to:
 participate in UK Biobank, including initial interview,
physical assessment, blood sampling and additional
data collection on diet
 be contacted again in the future and invited to take
part in further postal assessment or additional studies
 be agreeable to the manual inspection and recording
of historical routine health data and information
held in general practice and hospital records for the
purpose of follow-up
 the automated record linkage of information held
in computerised medical records in general practices
and hospitals throughout NHS Scotland.
Security and encryption
The clinical information would be stored on a
Structured Query Language (SQL) database. The first
level of security on clinical data is imposed by 
the NHSnet. A log-in screen would be presented and 
all communications encrypted. Access would be
determined by username and password. All attempts
to log on to the Scottish RCC server and every action
subsequently taken would be logged, producing audit
trails. All clinical data will be anonymised with all
patient-identifiable information removed before being
passed for analyses, according to the UK Biobank pro-
tocol. This system has already been employed by the
Health Informatics Centre and MEMO (Medicines
Monitoring Unit) at the University of Dundee, and
was consulted as part of the Confidentiality, Security
and Advisory Group’s report on patient confidentiality
in NHS Scotland. Thus, every patient, GP, general
practice and hospital clinic is allocated a unique,
randomly generated identifier, intended for the pur-
poses of anonymous research. Researchers are then
restricted to ‘views’ of data that use these anonymous
identifiers and omit any identifying fields. Thus, all
demographic information is removed except sex,
age (in months) and social class (Carstairs Index).
For genetic research, only the nurse performing the
fieldwork has access to the CHNo. This nurse does not
have access to any other patient-specific data other
than those collected during direct patient contact. In
addition, though the system administrator (through
necessity) has access to all data on the server, the
identity of individual genetic markers would not be
available to them.
Informed consent
Regardless of any of the above, the patient is
ultimately in control. The SQL system fully supports
informed consent though the use of consent granting
and denial forms that are scanned directly into the
central database using optical character recognition.
Should consent be denied, all records pertaining to
that patient, with the exception of that patient’s unique
identifiers, are deleted. If consent is subsequently denied,
any new data for that patient would be automatically
deleted.
A key part of the Scottish RCC proposal is that
electronic record linkage and fieldwork means that
once enrolled, longitudinal follow-up is automated to
allow tracking of all phenotypic end-points (for example,
disease progression, all drug use, all primary care
consultations, hospital admissions, investigations and
death). It is also possible through the CHNo to track
patients who migrate to other regions of Scotland to
reduce losses to follow-up. We anticipate the develop-
ment of methods to ensure Scottish procedures are
compatible with the other five regions.
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Data handling solutions
Baseline UK Biobank: 
fieldwork data collection
Following written informed consent, all clinical 
data collected at the screening visit would be
checked, coded and scanned electronically to allow
semi-automated data capture and storage of forms
as computerised images. This would be co-ordinated
by the hub.
UK Biobank Scottish RCC: 
automated data follow-up
Automated follow-up of electronic records of indi-
viduals is a novel feature of the Scottish component of
UK Biobank. This would create an extremely efficient
infrastructure for future research using UK Biobank
data collected in Scotland. This would be enabled 
by the use of the CHNo and our established track
record in record linkage of general practice, hospital,
pharmacy and the Registrar General datasets. The
NHS Scotland IM&T Strategy that is currently being
implemented in every trust in Scotland advocates the
administration of electronic health records through
centralised record linkage techniques, using the
CHNo as the unique patient identifier.18 This is the
Scottish Care Information (SCI) initiative. This strat-
egy would clearly support the automated follow-up
of all individuals enrolled into UK Biobank in
Scotland.
Role of CHNo in facilitating
automated follow-up 
Every person who is registered with a general practice
in Scotland is allocated a unique identifying number
(CHNo). This is a ten-digit integer, the first six digits
being the date of birth. Therefore every resident who
is registered with a GP appears in the continuously
updated computerised record, the Community Health
Index (CHI). This file contains data on address, post-
code, GP, deceased persons and date of death. Thus,
the demographic breakdown of Scotland, death and
patient migration can be easily analysed. The CHNo 
is used as the patient identifier in all primary
healthcare activities in Scotland. In some areas
(Dumfries and Galloway and Tayside), it is already
used for all healthcare events in primary and
secondary care.
Commitment of NHS Scotland 
to use the CHNo
NHS Scotland is committed to the principle that all
people can easily register for general NHS Scotland
services, specifically with a GP and dental practice,
and change aspects of that registration with minimal
impact on continuity of care, including a mechanism
to facilitate the transfer of a GP patient summary
from their old practice to the new. In addition there is
a commitment that core identification data are main-
tained, including CHNo, in such a way that all
contributors to care can use the data when and wherever
required. Currently, the existing Community Health
Index is being developed towards a system to be
known as the SCI Index. A major part of this is the
synchronisation of all principal master patient indices
(MPI) used by primary care, secondary care and national
systems. This is achieved by ensuring all MPIs carry
the CHNo and that these are electronically generated
from the main CHI as the source index. Obtaining
electronic access to the main CHI through a number
of approved access methods now available does this.
The SCI initiative has used these techniques to
implement a product called ‘SCI Store’ that is a central
repository of all patient data. Clinical information is
collected from legacy systems and stored in SCI Store
and coded according to SNOMED-CT. It is currently
installed in various stages in 11 out of 15 health
boards within Scotland.
Linkage of historical data
Where the CHNo number is not available (such as for
historical data), probability matching can be used,
whereby a number of patient-identifiable fields are
linked to calculate an overall probability of a match
being due to chance, and a predetermined cut-off
is then applied. The record linkage unit within the
Information Statistics Division (ISD) of NHS Scotland
has extensive experience of using probability match-
ing to link research databases to routine admission
and death data. This method has been used frequently
within Scotland to provide follow-up information on
admissions and deaths in research studies.
Proposed automated linkage to be
developed in Scotland
The UK Biobank Scottish RCC proposal involves the
establishment of one database server running SQL
Server 2000 and one web server. This ‘consortium’ server
would manage all data collected from the four
Scottish centres that are partners in this Scottish RCC.
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Flagging of UK Biobank participants
Following written informed consent by UK Biobank
participants, an electronic ‘flag’ could be attached to
the CHNo of that individual in the electronic systems
that hold relevant healthcare information. These
would be:
 the primary care legacy system (GPASS in the majority
of practices)
 all SCI Stores in NHS Scotland
 the Scottish Morbidity Record (SMR) returns made
to ISD.
We propose that information from these systems would
be extracted on a nightly basis, using an established
software application called Generic Importer and Ex-
porter (GENIE) that has been used in NHS Scotland
for the past two years in the context of SCI Diabetes,
a national diabetes computing system (SCI-DC).
What is GENIE?
Automating the collection of information from
different computer systems appears on the surface to
be a simple task. Unfortunately this is not the case and
the difficulty in achieving automation is illustrated by
how uncommon this still is. The Scottish RCC of UK
Biobank would address this problem through the use
of a tool that greatly simplifies the task. Assuming a
system can export its data to a text file (all the proposed
feeder systems meet this requirement), GENIE can
deal with the rest.
GENIE resides on a computer located on the site 
of the feeder computer system, that is, the general
practice or SCI Store. At a time scheduled by GENIE,
a snapshot of data is exported to a text file. GENIE
compares this snapshot with the previous day’s. Records
that are new, modified or deleted (a small number
each day) are then placed ready for transmission to
UK Biobank. At a predefined time, these records are
encrypted, compressed and transmitted to the site of
the UK Biobank database server that is linked to the
NHSnet. Should this transmission fail, records are
queued for later transmission. On arrival at the central
computer, the files are uncompressed and unencrypted.
The data are then mapped, imported and merged
with existing patient information. A schematic of the
proposed infrastructure is shown in Figure 1. This is
adapted from the system that is already in daily use for
SCI-DC.
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Figure 1 A schematic of the proposed automated structure
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Quality assurance of data
Although there could be a single server for the
Scottish RCC, the server could be partitioned so that
only the research team that has recruited specific patients
would be able to validate, supplement or quality-
assure stored information via web-based technology.
Users access the system via web browsers. A link to the
national CHI database would ensure that the system
knows who is alive or dead and which practice patients
are registered with. The databases, web servers and
back-up systems would be located in a secure machine
room. Centrally, back-up resources, a GENIE server
and a connection to NHSnet are required.
There are clear benefits of using this method to
automate follow-up both during and after funding
runs out for the main study. The benefits of a nightly
download of prescribing history and events would
give added value to the entire UK Biobank project.
Thus we would gather information on event rates and
prescribing rates that will be invaluable in powering
genetic epidemiology and pharmacogenetic studies
involving the whole 500 000 cohort. The datasets that
we propose to use for automated record linkage are
shown in Table 1.
We have proposed that the automated data manage-
ment would be co-ordinated by the Health Informatics
Centre at the University of Dundee and the Infor-
mation and Statistics Division of the NHS in Scotland
in a distributed model. Ultimately, a UK solution will
be defined to which Scotland, like the other RCCs, will
adhere. Some of these principles and mechanisms
may be of interest to others in primary care who are
using informatics tools and engaged in recruitment
and follow-up of large numbers of patients.
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